Treatment
Rosuvastatin clinical trials
We’re tracking 41 recruiting studies that include Rosuvastatin, each written for real people, not researchers, below.
Recruiting studies
- NCT07619118RecruitingPhase 3
Laroprovstat and rosuvastatin vs. rosuvastatin for high cholesterol
This trial tests whether adding a new medicine, laroprovstat, to a standard cholesterol drug (rosuvastatin) is better at lowering bad cholesterol than the standard drug alone. It might help people who are at high risk for heart disease or stroke.
Sun City West, ArizonaAges 18–130 - NCT07619131RecruitingPhase 3
New cholesterol-lowering combination pill for at-risk adults
This study tests a new combination pill containing two cholesterol-lowering medications (laroprovstat and rosuvastatin) in people who have never taken cholesterol medicine before. The goal is to see if the combination works better than either medicine alone at lowering LDL cholesterol, which is the 'bad' cholesterol that can increase heart disease risk.
Dothan, AlabamaAges 18–130 - NCT04499859RecruitingPhase 4
Low-dose cholesterol medicines versus high-dose after heart attack
This study compares two cholesterol treatment approaches after a heart attack: a lower dose combination versus a higher dose single medicine. It aims to see which option works well and is tolerable for people after a treated heart attack.
Bucheon-si, GyeonggidoAges 19 years+ - NCT06231966Recruiting
High-dose statin combo vs. standard statin for artery disease
This trial compares a high-dose combination of rosuvastatin (a statin) and ezetimibe (another cholesterol-lowering drug) versus a standard rosuvastatin-only approach for people with peripheral artery disease (narrowed leg arteries) or widespread artery disease. The goal is to see which strategy better lowers LDL cholesterol and reduces heart and limb risks.
SeoulAges 19–80 - NCT06186037RecruitingPhase 4
Lower-dose combo vs. higher-dose alone for heart artery disease
This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.
Suwon, Gyeonggi-doAges 19 years+ - NCT07446400RecruitingPhase 1
Drug interaction study for repinatrabit
This trial tests how repinatrabit interacts with common medications like birth control, metformin, and others. It helps doctors understand safe dosing and potential side effects.
Melbourne, VictoriaAges 18–55 - NCT07372625RecruitingPhase 1
How rezatapopt affects common drugs in advanced solid tumors with TP53 Y220C mutation
This trial tests how rezatapopt changes the way your body processes four common medicines (metformin, rosuvastatin, repaglinide, and midazolam) in people with advanced solid tumors that have a specific TP53 Y220C gene change. It helps doctors understand the right dose for future patients.
Denver, ColoradoAges 18 years+ - NCT06765265RecruitingPhase 4
Comparing two statins' effect on vitamin D after heart attack
This study compares two common statins (atorvastatin and rosuvastatin) to see how they affect vitamin D levels in people who have recently had a heart attack or unstable angina. It may help doctors choose the best statin for your heart and vitamin D health.
Lahore, Punjab ProvinceAges 18–65 - NCT06360120RecruitingPhase 3
Clopidogrel plus a statin for large-vessel stroke recovery
This study tests whether adding clopidogrel (a blood thinner) to atorvastatin or rosuvastatin (cholesterol-lowering drugs) helps people who had a first-time large-vessel ischemic stroke. It aims to find the best way to prevent another stroke.
Kafr ash ShaykhAges 18–75 - NCT06358313RecruitingPhase 3
Clopidogrel with statins for small vessel stroke
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
Kafr ash ShaykhAges 18–75 - NCT05832229RecruitingPhase 2
Liver cirrhosis network rosuvastatin trial
This study tests whether the drug rosuvastatin, a cholesterol-lowering medicine, can improve liver health in people with cirrhosis. If you have compensated cirrhosis (no recent serious liver problems), you might be able to join.
La Jolla, CaliforniaAges 18–75 - NCT04602754RecruitingPhase 3
Oral treatment test for type 2 diabetes and bad cholesterol
This Phase 3 study tests whether Berlim 25/20 can improve blood sugar control and cholesterol (LDL) in adults with type 2 diabetes who haven’t met targets despite prior lifestyle guidance and treatment. It also looks at safety, including effects on the heart and medication-related side effects.
Campinas, São PauloAges 18–85 - NCT07855250RecruitingPhase 1
How rilzabrutinib interacts with common drug transporters
This study checks how the investigational medicine rilzabrutinib affects proteins in your body that help clear certain drugs. It helps make sure other medications you take are safe and work properly.
Québec, QuebecAges 18–55 - NCT07820891RecruitingPhase 1
Healthy volunteer study for BGB-43395 drug interactions
This study tests whether a new medicine, BGB-43395, interacts with other drugs in healthy people. It helps doctors understand how the drug is processed, which is important for future patients.
Dallas, TexasAges 18–65 - NCT07704918Recruiting
Study: Lowering cholesterol during melanoma immunotherapy
This study tests whether giving aggressive cholesterol-lowering medication to people starting immunotherapy for melanoma can improve heart health. It may help reduce the risk of heart problems during cancer treatment.
Aurora, ColoradoAges 55 years+ - NCT07629999RecruitingPhase 1
Safety study of experimental drug BMS-986533 in healthy people
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
Lincoln, NebraskaAges 18–55 - NCT07568574Enrolling by invitation
Medical Study of Performance-Enhancing Substances in Elite Athletes
This study looks at how medically supervised performance-enhancing substances affect elite athletes' health and quality of life. Participants must be retired from professional sports and willing to undergo careful medical monitoring throughout the trial.
Abu DhabiAges 18 years+ - NCT04699279Recruiting
Statin after aortic surgery to protect heart and organs
This trial tests whether taking a cholesterol-lowering medicine (a statin) after certain aortic surgeries can reduce harmful changes in the heart and other organs. You might benefit by lowering the risk of ongoing damage after your acute aortic condition and surgery.
Guangzhou, GuangdongAges 18–85 - NCT07550816RecruitingPhase 1
Safety study of ZT002 injection in overweight adults
This study tests how a new diabetes medicine called ZT002 works in the body and whether it interacts safely with other common medications. Researchers will monitor healthy volunteers who are overweight to understand the medicine's safety and effectiveness.
Chengdu, SichuanAges 18–45 - NCT05155137RecruitingPhase 3
Daily pill and home risk check to prevent stroke and memory loss
This Phase 3 trial tests whether a daily “polypill” plus a simple home risk-check plan can lower the chance of stroke and future thinking/memory problems. It is aimed at adults at moderate risk but who have not had stroke or heart disease before.
Porto Alegre, Rio Grande do SulAges 50–75 - NCT07460960RecruitingPhase 2
Statin therapy for heart health and erectile function in men
This study tests whether statins, a common cholesterol-lowering medication, can improve erectile function and hormone levels in men at high risk for heart problems. It aims to see if these benefits exist beyond just lowering cholesterol.
MoscowAges 40–65 - NCT06804980RecruitingPhase 4
Rosuvastatin Tolerance for People with Statin Side Effects
This trial tests a low dose of rosuvastatin (a common statin) in people who have had trouble with statins before. The goal is to see if your body can tolerate this specific dose again, which could help lower your cholesterol without the past side effects.
Minneapolis, MinnesotaAges 21 years+ - NCT06338293RecruitingPhase 4
Inclisiran plus statins for fragile heart plaque
This trial tests if adding inclisiran to your current statin can reduce dangerous, rupture-prone plaque in your heart arteries. It may help if you have a moderate blockage with thin-cap plaque and your LDL cholesterol stays high despite statins.
Nanjing, JiangsuAges 18–80 - NCT07339722RecruitingPhase 1
Study of LY4515100 in healthy volunteers
This trial tests a new oral medication in healthy volunteers to see how it moves through the body and how safe it is. Taking part helps researchers understand how the drug works before it's studied in people with a certain condition.
Dallas, TexasAges 18–65
What Rosuvastatin is being studied for
Conditions with recruiting Rosuvastatin studies.
Common questions
- Are there clinical trials studying Rosuvastatin?
- Yes. Clin2 currently lists 41 recruiting studies that include Rosuvastatin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Rosuvastatin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Rosuvastatin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Rosuvastatin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.